Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-07-26
1990-02-27
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
548498, C07D48704, A01K 3155
Patent
active
049046543
ABSTRACT:
A metabolite of the known anxiolytic agent, 7-chloro-5,6-dihydro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4 H- imidazo[1,5a][1,4]benzodiazepine is a 2-hydroxy derivative of the isopropyl moiety and is itself an anxiolytic agent.
REFERENCES:
patent: 4507313 (1985-03-01), Braestrup et al.
patent: 4775671 (1988-10-01), Hunkeler
Lin Jiunn H.
Pitzenberger Steven M.
Ramjit Harri G.
Ulm Edgar H.
DiPrima Joseph F.
Gerstl Robert
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isoprop yl)-1,2,4-oxadiazol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isoprop yl)-1,2,4-oxadiazol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isoprop yl)-1,2,4-oxadiazol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174324